Ozel Liv Hospital

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Childhood cancers2 trials
• Melanoma2 trials
• Lung cancer1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Active, not recruiting3 trials

Lead sponsor

• Regeneron Pharmaceuticals3 trials

Running trials

• Active, not recruiting

  A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1)

  NCT05557591· Phase 2· Regeneron Pharmaceuticals· Source

• Active, not recruiting

  A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery

  NCT05608291· Phase 3· Regeneron Pharmaceuticals· Source

• Active, not recruiting

  Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma

  NCT05352672· Phase 3· Regeneron Pharmaceuticals· Source